A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.
The proportion of people with dementia in rural and regional Australia is consistent with that of metropolitan areas. Access to diagnosis and support however is not.
In a world first, Australian researchers have discovered a new mechanism in the brain that has the potential to reduce the impact of debilitating neuroinflammatory diseases.
New findings from a collaboration of researchers from NeuRA, UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) and the University of Sydney shed light on Alzheimer's disease treatments.
An international research study led by the Centre for Healthy Brain Ageing (CHeBA) provides further support to the finding that more education is associated with a decreased risk of dementia.
CHeBA is proud to present Professor Ron Petersen of Mayo Clinic, for his talk: Diagnosing Alzheimer’s Disease in the Biomarker Era: Promises and Pitfalls
